Literature DB >> 2860471

Clinical resistance to long-term oral ciprofloxacin.

S M Crook, J B Selkon, P D McLardy Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860471     DOI: 10.1016/s0140-6736(85)92343-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Isolation of fluoroquinolone-resistant Escherichia coli and Klebsiella pneumoniae from an infected Hickman catheter.

Authors:  M López-Brea; T Alarcón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

2.  Clinical uses of nalidixic acid analogues: the fluoroquinolones.

Authors:  N Høiby
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

3.  Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci.

Authors:  M S Simberkoff; J J Rahal
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

4.  The place of quinolones in antibacterial therapy in hospitals.

Authors:  R P Mouton
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

Review 5.  Development of resistance during antibiotic therapy.

Authors:  D Milatovic; I Braveny
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

6.  Ciprofloxacin resistance in clinical isolates of Pseudomonas aeruginosa from Italian patients.

Authors:  G Corti; F Paradisi; E Giganti; G Buffini; E Tortoli; L Martelli; P Pecile; P Nicoletti
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 7.  Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

8.  Occurrence of quinolone resistance in Staphylococcus aureus from nosocomial infection.

Authors:  W Witte; H Grimm
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

Review 9.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

10.  Reduced susceptibilities of Shigella sonnei strains isolated from patients with dysentery to fluoroquinolones.

Authors:  S Horiuchi; Y Inagaki; N Yamamoto; N Okamura; Y Imagawa; R Nakaya
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.